Study shows how to get more Aids drugs to more people

By Incorrect Author 10 December 2009

A new study published in Britain’s Lancet medical journal reveals that costly and routine laboratory monitoring of toxic side effects of HIV/Aids drugs can be dropped with little concern. Researchers say the money can better be used to increase access to new types of drugs. The study shows that among thousands of people monitored in Uganda and Zimbabwe, which are hard-hit by HIV infections, testing for side effects had no significant impact on survival rates. It’s a case of getting more bang for one’s buck, as many more sufferers could be treated with anti-retroviral therapy using the money saved. The World Health Organisation now prefers standard ART, which uses at least three anti-retroviral drugs to optimally suppress the HI virus. It says it has seen huge reductions in death rates using this regimen. Read more: BBC, World Health Organisation

Gallery

While we have your attention...

An increasingly rare commodity, quality independent journalism costs money - though not nearly as much as its absence.

Every article, every day, is our contribution to Defending Truth in South Africa. If you would like to join us on this mission, you could do much worse than support Daily Maverick's quest by becoming a Maverick Insider.

Click here to become a Maverick Insider and get a closer look at the Truth.


DAYS OF ZONDO

Banks tell inquiry of their resistance to Zwane’s bullying tactics

By Jessica Bezuidenhout

Iceland is the only country without mosquitoes.